ClinicalTrials.Veeva

Menu
S

Shatabdi Super Speciality Hospital | Oncology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Paclitaxel
Carboplatin
Bevacizumab
TAR-200
PF-06439535
Cisplatin
Trastuzumab
Tamibarotene
MT-102
Gemcitabine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 7 total trials

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (SunRISe-2)

The purpose of study is to compare bladder intact-event free survival (BI-EFS) in participants receiving TAR-200 in combination with intravenous (IV)...

Active, not recruiting
Urinary Bladder Neoplasms
Drug: Cisplatin
Radiation: Hypo-fractioned radiation therapy

Trial sponsors

Pfizer logo
A
C
Janssen (J&J Innovative Medicine) logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems